Johnson & Johnson Vision Care, Inc.
jnj.comTotal trials
219
Active
1
Phase 3
1
Total enrollment
25,698
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Visual Acuity97
- Myopia42
- Astigmatism15
- Refractive Error13
- Presbyopia9
- Ocular Physiology6
- Visual Performance4
- Ametropia4
Frequently asked questions about Johnson & Johnson Vision Care, Inc.
- How many clinical trials does Johnson & Johnson Vision Care, Inc. have on ClinicalTrials.gov?
- Johnson & Johnson Vision Care, Inc. is listed as the lead sponsor on 219 clinical trials in ClinicalTrials.gov, 1 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Johnson & Johnson Vision Care, Inc.'s trials are in Phase 3?
- 1 of Johnson & Johnson Vision Care, Inc.'s trials are in Phase 3.
- What therapeutic areas does Johnson & Johnson Vision Care, Inc. focus on?
- Johnson & Johnson Vision Care, Inc.'s most-studied conditions on ClinicalTrials.gov are Visual Acuity, Myopia, Astigmatism, Refractive Error, Presbyopia.